We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Identifying Earlier Alzheimer's Disease: Insights from the Preclinical and Prodromal Phases.
- Authors
Molinuevo, Jose Luis; Sánchez-Valle, Raquel; Lladó, Albert; Fortea, Juan; Bartrés-Faz, David; Rami, Lorena
- Abstract
Alzheimer's disease (AD) has been traditionally conceptualized as a clinicopathological entity, its definite diagnosis requiring the presence of characteristic pathology together with a dementia clinical picture. The fact that certain AD biomarkers show an acceptable sensitivity and specificity to detect AD pathology has shifted the diagnostic paradigm towards a clinicobiological approach. The objective of this paper is to present recent data that show how cerebrospinal fluid (CSF) biomarkers behave in preclinical AD. These studies have been performed in presymptomatic subjects (PreS) and asymptomatic subjects at risk for the disease (AsymR). In brief, the results show in PreS subjects that CSF biomarkers present a positive correlation with time to disease onset to reach floor levels at symptom onset. In addition, memory performance presents distinct associations in the AD continuum, being related to Aβ1-42 levels in AsymR subjects and to t-tau and p-tau in prodromal AD. Furthermore, an increase in cortical thickness of typical AD areas was observed when mean Aβ1-42 levels were still within the normal range in PreS subjects, or they presented transitional values in AsymR subjects. Overall, these findings suggest that the preclinical stage is biologically active and that there may be structural changes when amyloid is starting its deposition. Copyright © 2011 S. Karger AG, Basel
- Subjects
ALZHEIMER'S disease; BIOMARKERS; CEREBROSPINAL fluid; DEMENTIA; PATHOLOGY
- Publication
Neurodegenerative Diseases, 2012, Vol 10, Issue 1-4, p158
- ISSN
1660-2854
- Publication type
Article
- DOI
10.1159/000332806